Baker, Andrew T.,Ross, Russell F.,Ranganathan, Sridhar
申请号：
AU2014270014
公开号：
AU2014270014A1
申请日:
2014.05.20
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
In one aspect a drug delivery device may include a reservoir containing a liquid drug formulation and a microneedle assembly in fluid communication with the reservoir. The microneedle assembly may include a plurality of microneedles, with each microneedle defining an open channel for receiving a drug formulation. The open channel may have a normalized hydraulic radius ranging from about 0.1 to about 0.8. The open channel may also have a Iiquid-to-solid interfacia! energy and a liquid-to-vapor interfacia! energy when a fixed volume of the drug formulation is received therein. In addition, the drug formulation and a cross-sectional geometry of the open channel may be selected and configured such that the liquid- to-solid energy exceeds the liquid-to-vapor energy as the length of the fixed volume of drug formulation is increased within the open channel.
